Crossmark

Study on the potential active components and molecular mechanism of Xiao Huoluo Pills in the treatment of cartilage degeneration of knee osteoarthritis based on bioinformatics analysis and molecular docking technology

Crossref DOI link: https://doi.org/10.1186/s13018-021-02552-w

Published Online: 2021-07-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Weijian

Lin, Tianye

He, Qi

Yang, Peng

Zhang, Gangyu

Huang, Fayi

Wang, Zihao

Peng, Hao

Li, Baolin

Liang, Du

Wang, Haibin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81774339, 82074462)
License Information

Text and Data Mining valid from 2021-07-17

Version of Record valid from 2021-07-17
More Information

Article History

Received: 7 May 2021

Accepted: 15 June 2021

First Online: 17 July 2021

Declarations

:

: This study was conducted in agreement with the Declaration of Helsinki and its later amendments or comparable ethical standards and had been approved by the ethics board of The First Affiliated Hospital of Guangzhou University of Chinese Medicine (No: Y《2020》119).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below